Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden

[1]  H. Olsson,et al.  A population-based cohort study of HRT use and breast cancer in southern Sweden , 2001, British Journal of Cancer.

[2]  R. Kaaks,et al.  Energy balance and cancer: the role of insulin and insulin-like growth factor-I , 2001, The Proceedings of the Nutrition Society.

[3]  R. Shore,et al.  Serum insulin‐like growth factor‐I and breast cancer , 2000, International journal of cancer.

[4]  I. McCutcheon,et al.  The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. , 2000, Endocrine reviews.

[5]  D. Trichopoulos,et al.  Leptin and insulin growth factor I in relation to breast cancer (Greece) , 2000, Cancer Causes & Control.

[6]  H. Wennbo,et al.  The role of prolactin and growth hormone in breast cancer , 2000, Oncogene.

[7]  H. Adami,et al.  Breast‐cancer risk following long‐term oestrogen‐ and oestrogen‐progestin‐replacement therapy , 1999, International journal of cancer.

[8]  R. Dickson,et al.  Growth Factors, Apoptosis, and Survival of Mammary Epithelial Cells , 1999, Journal of Mammary Gland Biology and Neoplasia.

[9]  C. Mantzoros,et al.  Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. , 1998, Epidemiology.

[10]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[11]  D. Leroith,et al.  Growth hormone treatment induces mammary gland hyperplasia in aging primates , 1997, Nature Medicine.

[12]  D. Clemmons.  Insulin-like growth factor binding proteins and their role in controlling IGF actions. , 1997, Cytokine & growth factor reviews.

[13]  R. Kaaks.  Nutrition, hormones, and breast cancer: Is insulin the missing link? , 1996, Cancer Causes & Control.

[14]  M Hammar,et al.  Hormone replacement therapy and previous use of oral contraceptives among Swedish women. , 1996, Maturitas.

[15]  T. C. Linders,et al.  Insulin‐like growth‐factor‐binding protein 3 is decreased in early‐stage operable pre‐menopausal breast cancer , 1995, International journal of cancer.

[16]  C. Campagnoli,et al.  Potential impact on breast cancer risk of circulating insulin-like growth factor I modifications induced by oral HRT in menopause. , 1995, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[17]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[18]  J. Ketelslegers,et al.  Nutritional regulation of the insulin-like growth factors. , 1994, Endocrine reviews.

[19]  G. Berglund,et al.  Design and feasibility , 1993 .

[20]  A. A. Hart,et al.  Insulin resistance and breast‐cancer risk , 1992, International journal of cancer.

[21]  D. Hadsell,et al.  IGF and Insulin Action in the Mammary Gland: Lessons from Transgenic and Knockout Models , 2004, Journal of Mammary Gland Biology and Neoplasia.

[22]  I. G. Fantus,et al.  Insulin and related factors in premenopausal breast cancer risk , 2004, Breast Cancer Research and Treatment.

[23]  C. Campagnoli,et al.  Effect of progestins on IGF-I serum level in estrogen-treated postmenopausal women. , 1997, Zentralblatt fur Gynakologie.

[24]  A. O’Sullivan,et al.  Sex steroid regulation of growth hormone secretion and action. , 1996, Hormone research.

[25]  G. Berglund,et al.  The Malmo Diet and Cancer Study. Design and feasibility. , 1993, Journal of internal medicine.